These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


319 related items for PubMed ID: 15188377

  • 1. T cell receptors recognizing type II collagen in HLA-DR-transgenic mice characterized by highly restricted V beta usage.
    He X, Rosloniec EF, Myers LK, McColgan WL, Gumanovskaya M, Kang AH, Stuart JM.
    Arthritis Rheum; 2004 Jun; 50(6):1996-2004. PubMed ID: 15188377
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice.
    Sakurai Y, Brand DD, Tang B, Rosloniec EF, Stuart JM, Kang AH, Myers LK.
    Arthritis Res Ther; 2006 Jun; 8(5):R150. PubMed ID: 16982003
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Epitope specificity and T cell receptor usage in type II collagen induced autoimmune ear disease.
    Yoo TJ, Lee MK, Min YS, Chiang HJ, Wang K, Fujiyoshi T, Watanabe T, Krug MS, Seyer J, Cheng KC.
    Cell Immunol; 1994 Aug; 157(1):249-62. PubMed ID: 7518752
    [Abstract] [Full Text] [Related]

  • 10. Immunopathogenesis of collagen arthritis.
    Brand DD, Kang AH, Rosloniec EF.
    Springer Semin Immunopathol; 2003 Aug; 25(1):3-18. PubMed ID: 12904888
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. BUB/BnJ (H-2q) is a TCR deletion mutant mouse strain (TCR V beta a, KJ16-) that is susceptible to type II collagen-induced arthritis.
    Ortman RA, Holderbaum D, Qu XM, Banerjee S, Haqqi TM.
    J Immunol; 1994 Apr 15; 152(8):4175-82. PubMed ID: 8144978
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Restricted TCR V alpha repertoire in the T cell response to a tolerogenic determinant of type II collagen.
    Kawamura S, Miyahara H, Esaki Y, Myers LK, Rosloniec EF, Stuart JM, Kang AH.
    J Immunol; 1997 Jun 15; 158(12):6013-8. PubMed ID: 9190956
    [Abstract] [Full Text] [Related]

  • 18. Diversity and dominance among TCR recognizing HLA-A2.1+ influenza matrix peptide in human MHC class I transgenic mice.
    Man S, Ridge JP, Engelhard VH.
    J Immunol; 1994 Nov 15; 153(10):4458-67. PubMed ID: 7963521
    [Abstract] [Full Text] [Related]

  • 19. Nonrandom T cell receptor usage in the allorecognition of HLA-DR1 microvariation.
    Hurley CK, Steiner N, Wagner A, Geiger MJ, Eckels DD, Rosen-Bronson S.
    J Immunol; 1993 Feb 15; 150(4):1314-24. PubMed ID: 8381833
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.